{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:07:47Z","timestamp":1777396067397,"version":"3.51.4"},"reference-count":62,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2021,11,23]]},"abstract":"<jats:p>Background: Positive and negative allosteric modulators of \u03b15 GABAA receptors (PAM and NAM, respectively) are worthy of investigation as putative treatments of Alzheimer\u2019s disease (AD). However, their potential to modify a dynamic range of behaviors in AD models needs to be systematically examined. Objective: The study aimed to assess effects of MP-III-022 as PAM and PWZ-029 as NAM on emotional reactivity, motivation, and motor function, as well as on gene expression of GABRA2, GABRA3 and GABRA5 subunit of GABAA receptors in prefrontal cortex (PFC) and hippocampus (HC) in 5xFAD mice, as an early-onset transgenic AD model. Methods: The 6-month-old 5xFAD transgenic and non-transgenic mice of both genders underwent a battery of reflexes and behavioral tests (sensorimotor tests, elevated plus maze, and open field) after 10-day intraperitoneal treatment with MP-III-022, PWZ-029, or solvent. The behavioral battery was followed by qPCR analysis of gene expression. Results: MP-III-022 induced a decline in motor function, while PWZ-029 further decreased emotionality of transgenic males, as compared to the transgenic control. No interfering effects on non-cognitive behavior were observed in female mice. In HC, both treatments reversed reciprocal GABRA2 and GABRA3 changes in transgenic females. In PFC, MP-III-022 decreased GABRA5 in both genders, while PWZ-029 increased GABRA2 in male transgenic animals. Conclusion: Gender-dependent protracted effects of PAMs and NAMs in AD model, with detrimental impact on motor capabilities of PAM, and attenuation of emotionality elicited by NAM in transgenic males, were revealed. This favors future research of \u03b15 GABAA receptor modulation in females as more promising.<\/jats:p>","DOI":"10.3233\/jad-215079","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T18:07:00Z","timestamp":1634148420000},"page":"1291-1302","source":"Crossref","is-referenced-by-count":7,"title":["Positive and Negative Selective Allosteric Modulators of \u03b15 GABAA Receptors: Effects on Emotionality, Motivation, and Motor Function in the 5xFAD Model of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"84","author":[{"given":"Jovana","family":"Aran\u0111elovi\u0107","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja","family":"Santra\u010d","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojan","family":"Batini\u0107","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Todorovi\u0107","sequence":"additional","affiliation":[{"name":"Laboratory for Radiobiology and Molecular Genetics, Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Zubair","family":"Ahmed Khan","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farjana","family":"Rashid","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael M.","family":"Poe","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandar","family":"Obradovi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[{"name":"Department of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, WI, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miroslav M.","family":"Savi\u0107","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-215079_ref1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3233\/JAD-191092","article-title":"The prevalence of dementia: A systematic review and meta-analysis","volume":"73","author":"Cao","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-215079_ref2","first-page":"9213968","article-title":"Assessment of health-related quality of life for caregivers of Alzheimer\u2019s disease patients","volume":"2016","author":"Andreakou","year":"2016","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-215079_ref3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1474-4422(16)00062-4","article-title":"Defeating Alzheimer\u2019s disease and other dementias: A priority for European science and society","volume":"15","author":"Winblad","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-215079_ref4","doi-asserted-by":"crossref","first-page":"9944","DOI":"10.1073\/pnas.1301119110","article-title":"Heightened emotional contagion in mild cognitive impairment and Alzheimer\u2019s disease is associated with temporal lobe degeneration","volume":"110","author":"Sturm","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-215079_ref5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12888-015-0666-8","article-title":"Motivational processes in mild cognitive impairment and Alzheimer\u2019s disease: Results from the Motivational Reserve in Alzheimer\u2019s (MoReA) study","volume":"15","author":"Forstmeier","year":"2015","journal-title":"BMC Psychiatry"},{"key":"10.3233\/JAD-215079_ref6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jalz.2014.04.514","article-title":"At the interface of sensory and motor dysfunctions and Alzheimer\u2019s disease","volume":"11","author":"Albers","year":"2015","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-215079_ref7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrn1625","article-title":"Variations on an inhibitory theme: Phasic and tonic activation of GABA(A) receptors","volume":"6","author":"Farrant","year":"2005","journal-title":"Nat Rev Neurosci"},{"key":"10.3233\/JAD-215079_ref8","doi-asserted-by":"crossref","first-page":"4960","DOI":"10.2174\/1381612821666150914121149","article-title":"Treatment options in Alzheimer\u2019s disease: The GABA story","volume":"21","author":"Solas","year":"2015","journal-title":"Curr Pharm Des"},{"key":"10.3233\/JAD-215079_ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fnagi.2016.00031","article-title":"Implications of GABAergic neurotransmission in Alzheimer\u2019s Disease","volume":"8","author":"Li","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-215079_ref10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/jnc.14345","article-title":"The GABAergic system as a therapeutic target for Alzheimer\u2019s disease","volume":"146","author":"Calvo-Flores Guzm\u00e1n","year":"2018","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215079_ref11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/jnc.14325","article-title":"GABAA receptor subunit expression changes in the human Alzheimer\u2019s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus","volume":"145","author":"Kwakowsky","year":"2018","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215079_ref12","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABA A receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-215079_ref13","first-page":"613","article-title":"Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer\u2019s disease","volume":"117","author":"Rissman","year":"2011","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-215079_ref14","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9947.1","article-title":"Disinhibition, an emerging pharmacology of learning and memory","volume":"6","author":"M\u00f6hler","year":"2017","journal-title":"F1000Res"},{"key":"10.3233\/JAD-215079_ref15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2174\/1389450116666150309120235","article-title":"Selective modulators of \u03b15-containing GABAA receptors and their therapeutic significance","volume":"16","author":"Soh","year":"2015","journal-title":"Curr Drug Targets"},{"key":"10.3233\/JAD-215079_ref16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fnmol.2019.00179","article-title":"Neurobiology and therapeutic potential of \u03b15-GABA type A receptors","volume":"12","author":"Jacob","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-215079_ref17","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.jmedchem.9b01312","article-title":"Subtype selective \u03b3-aminobutyric acid type A receptor (GABAAR) modulators acting at the benzodiazepine binding site: An update","volume":"63","author":"Maramai","year":"2020","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-215079_ref18","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fphar.2016.00446","article-title":"Sex-dependent anti-stress effect of an \u03b15 subunit containing GABAA receptor positive allosteric modulator","volume":"7","author":"Piantadosi","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-215079_ref19","first-page":"pyab002","article-title":"Behavioral deficits induced by somatostatin-positive GABA neuron silencing are rescued by alpha 5 GABA-A receptor potentiation","volume":"13","author":"Fee","year":"2021","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.3233\/JAD-215079_ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1523\/ENEURO.0285-16.2017","article-title":"A negative allosteric modulator for \u03b15 subunit- containing GABA receptors exerts a rapid and persistent antidepressant-like action without the side effects of the NMDA receptor antagonist ketamine in mice","volume":"4","author":"Zanos","year":"2017","journal-title":"eNeuro"},{"key":"10.3233\/JAD-215079_ref21","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejphar.2016.09.016","article-title":"Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the \u03b15 subunit","volume":"791","author":"Stameni\u0107","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215079_ref22","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbr.2012.12.016","article-title":"PWZ-029, an inverse agonist selective for \u03b15 GABAA receptors, improves object recognition, but not water-maze memory in normal and scopolamine-treated rats","volume":"241","author":"Mili\u0107","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215079_ref23","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: Potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-215079_ref24","doi-asserted-by":"crossref","first-page":"172524","DOI":"10.1016\/j.ejphar.2019.172524","article-title":"Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer\u2019s disease","volume":"859","author":"Veening-Griffioen","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.3233\/JAD-215079_ref25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13024-017-0231-7","article-title":"Practical considerations for choosing a mouse model of Alzheimer\u2019s disease","volume":"12","author":"Jankowsky","year":"2017","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-215079_ref26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jagp.2020.04.026","article-title":"Neurobiologic rationale for treatment of apathy in Alzheimer\u2019s disease with methylphenidate","volume":"29","author":"van Dyck","year":"2021","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-215079_ref27","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1111\/bph.13850","article-title":"Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition","volume":"174","author":"Bast","year":"2017","journal-title":"Br J Pharmacol"},{"key":"10.3233\/JAD-215079_ref28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.neuroscience.2016.06.013","article-title":"Impact of anxiety on prefrontal cortex encoding of cognitive flexibility","volume":"345","author":"Park","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-215079_ref29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1146\/annurev.neuro.051508.135256","article-title":"Emotion, cognition, and mental state representation in amygdala and prefrontal cortex","volume":"33","author":"Salzman","year":"2010","journal-title":"Annu Rev Neurosci"},{"key":"10.3233\/JAD-215079_ref30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnagi.2015.00021","article-title":"Impaired emotional autobiographical memory associated with right amygdalar-hippocampal atrophy in Alzheimer\u2019s disease patients","volume":"7","author":"Philippi","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-215079_ref31","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.neuroimage.2004.07.002","article-title":"Prefrontal and premotor cortices are involved in adapting walking and running speed on the treadmill: An optical imaging study","volume":"23","author":"Suzuki","year":"2004","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-215079_ref32","doi-asserted-by":"crossref","first-page":"e0222064","DOI":"10.1371\/journal.pone.0222064","article-title":"Hippocampal connectivity with sensorimotor cortex during volitional finger movements: Laterality and relationship to motor learning","volume":"14","author":"Burman","year":"2019","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215079_ref33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: Novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.3233\/JAD-215079_ref34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-215079_ref35","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0006-8993(02)02566-0","article-title":"Impaired olfactory behavior in mice deficient in the \u03b1 subunit of Go","volume":"941","author":"Luo","year":"2002","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215079_ref36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jneumeth.2011.01.019","article-title":"Integrated behavioral z-scoring increases the sensitivity and reliability of behavioral phenotyping in mice: Relevance to emotionality and sex","volume":"197","author":"Guilloux","year":"2011","journal-title":"J Neurosci Methods"},{"key":"10.3233\/JAD-215079_ref37","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor subtype-and function-selective ligands: Key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.3233\/JAD-215079_ref38","first-page":"1","article-title":"A review of the updated pharmacophore for the alpha 5 GABA(A) benzodiazepine receptor model","volume":"2015","author":"Clayton","year":"2015","journal-title":"Int J Med Chem"},{"key":"10.3233\/JAD-215079_ref39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2008.02.020","article-title":"PWZ-029, a compound with moderate inverse agonist functional selectivity at GABAA receptors containing \u03b15 subunits, improves passive, but not active, avoidance learning in rats","volume":"1208","author":"Savi\u0107","year":"2008","journal-title":"Brain Res"},{"key":"10.3233\/JAD-215079_ref40","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1038\/ncomms5159","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzheimer\u2019s [corrected] disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-215079_ref41","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.neubiorev.2015.09.002","article-title":"The problem of genotype and sex differences in life expectancy in transgenic AD mice","volume":"57","author":"Rae","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-215079_ref42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNN.0000000000000020","article-title":"Feelings without memory in Alzheimer disease","volume":"27","author":"Guzm\u00e1n-V\u00e9lez","year":"2014","journal-title":"Cogn Behav Neurol"},{"key":"10.3233\/JAD-215079_ref43","first-page":"2","article-title":"Does emotional memory enhancement assist the memory-impaired?","volume":"4","author":"Broster","year":"2012","journal-title":"Front Aging Neurosci Mar"},{"key":"10.3233\/JAD-215079_ref44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1037\/0894-4105.14.1.82","article-title":"Memory enhancement for emotional stimuli is impaired in early Alzheimer\u2019s disease","volume":"14","author":"Hamann","year":"2000","journal-title":"Neuropsychology"},{"key":"10.3233\/JAD-215079_ref45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1037\/1528-3542.2.2.118","article-title":"Effects of normal aging and Alzheimer\u2019s disease on emotional memory","volume":"2","author":"Kensinger","year":"2002","journal-title":"Emotion"},{"key":"10.3233\/JAD-215079_ref46","doi-asserted-by":"crossref","first-page":"e0241562","DOI":"10.1371\/journal.pone.0241562","article-title":"Roles of the prefrontal cortex in learning to time the onset of pre-existing motor programs","volume":"15","author":"Lee","year":"2020","journal-title":"PLoS One"},{"key":"10.3233\/JAD-215079_ref47","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/ern.11.57","article-title":"Loss of motor function in preclinical Alzheimer\u2019s disease","volume":"11","author":"Buchman","year":"2011","journal-title":"Expert Rev Neurother"},{"issue":"96","key":"10.3233\/JAD-215079_ref48","first-page":"e52434","article-title":"Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice","author":"Seibenhener","year":"2015","journal-title":"J Vis Exp"},{"key":"10.3233\/JAD-215079_ref49","unstructured":"Bailey KR , Crawley JN (2009) Anxiety-related behaviors in mice. In: Methods of Behavior Analysis in Neuroscience. 2nd edition, Buccafusco JJ, ed. CRC Press\/Taylor & Francis, Boca Raton (FL). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK5221\/"},{"key":"10.3233\/JAD-215079_ref50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.12779\/dnd.2017.16.2.33","article-title":"Anxiety in dementia","volume":"16","author":"Kwak","year":"2017","journal-title":"Dement Neurocogn Disord"},{"key":"10.3233\/JAD-215079_ref51","doi-asserted-by":"crossref","first-page":"196.e29","DOI":"10.1016\/j.neurobiolaging.2010.05.027","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal A\u03b2 aggregation in the 5XFAD mouse model of Alzheimer\u2019s disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215079_ref52","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00213-018-4832-9","article-title":"Negative allosteric modulation of alpha 5-containing GABAA receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing mice","volume":"235","author":"Xu","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"key":"10.3233\/JAD-215079_ref53","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1017\/S1461145709000108","article-title":"The differential role of \u03b11- and \u03b15- containing GABAA receptors in mediating diazepam effects on spontaneous locomotor activity and water-maze learning and memory in rats","volume":"12","author":"Savi\u0107","year":"2009","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.3233\/JAD-215079_ref54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/7854_2015_380","article-title":"Methods for dissecting motivation and related psychological processes in rodents","volume":"27","author":"Ward","year":"2016","journal-title":"Curr Top Behav Neurosci"},{"key":"10.3233\/JAD-215079_ref55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1006\/hbeh.2002.1832","article-title":"Statistical analysis of hormonal influences on arousal measures in ovariectomized female mice","volume":"42","author":"Frohlich","year":"2002","journal-title":"Horm Behav"},{"key":"10.3233\/JAD-215079_ref56","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s12031-018-1246-4","article-title":"The \u03b15-containing GABAA receptors-a brief summary","volume":"67","author":"Mohamad","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-215079_ref57","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0496-18.2019","article-title":"GABAA receptors are well preserved in the hippocampus of aged mice","volume":"6","author":"Palpagama","year":"2019","journal-title":"eNeuro"},{"key":"10.3233\/JAD-215079_ref58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.bbr.2016.06.002","article-title":"Hippocampal proteomics defines pathways associated with memory decline and resilience in normal aging and Alzheimer\u2019s disease mouse models","volume":"322","author":"Neuner","year":"2017","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-215079_ref59","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/s41593-019-0539-4","article-title":"A single-cell atlas of entorhinal cortex from individuals with Alzheimer\u2019s disease reveals cell-type-specific gene expression regulation","volume":"22","author":"Grubman","year":"2019","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-215079_ref60","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.neurobiolaging.2012.12.026","article-title":"A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer\u2019s disease","volume":"34","author":"Antonell","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-215079_ref61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fnsys.2019.00010","article-title":"GABAA receptor subunit \u03b13 in network dynamics in the medial entorhinal cortex","volume":"13","author":"Berggaard","year":"2019","journal-title":"Front Syst Neurosci"},{"key":"10.3233\/JAD-215079_ref62","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/7854_2009_30","article-title":"GABAA receptor \u03b12\/\u03b13 subtype-selective modulators as potential nonsedating anxiolytics","volume":"2","author":"Atack","year":"2010","journal-title":"Curr Top Behav Neurosci"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-215079","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:29Z","timestamp":1777370849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-215079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,23]]},"references-count":62,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-215079","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,23]]}}}